Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3RFY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $91,242
Award facts
- Contract value 100% obligated
- $91,242.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $91,242.43 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA encompasses a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Dupixent—a biologic medication indicated for allergic diseases and eosinophilic conditions—exemplifies the company's role in supplying specialty brand-name pharmaceuticals to support the Defense Health Agency and other federal healthcare programs through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F3RFY?
SPE2DR26F3RFY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F3RFY worth?
The government has obligated $91,242 on SPE2DR26F3RFY.
Is contract SPE2DR26F3RFY an order under another contract?
Yes. SPE2DR26F3RFY is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RFY competed?
The extent of competition for SPE2DR26F3RFY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award